Neurogene (NGNE)
NASDAQ:NGNE
US Market
Holding NGNE?
Track your performance easily

Neurogene (NGNE) Income Statement

438 Followers

Neurogene Income Statement

Last quarter (Q2 2024), Neurogene's total revenue was $925.00K, an increase of Infinity% from the same quarter last year. In Q2, Neurogene's net income was $-18.49M. See Neurogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 925.00K---$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 925.00K-----
Operating Expense
$ 77.22M$ 55.58M$ -59.10M$ 60.70M$ 41.55M$ 23.24M
Operating Income
$ -76.30M$ -55.58M$ -59.10M$ -60.70M$ -41.55M$ -23.24M
Net Non Operating Interest Income Expense
$ 5.37M$ 2.94M$ -42.00K$ 6.00K$ 490.00K$ 1.54M
Other Income Expense
$ -738.00K$ 16.33M$ 118.00K$ 12.00K$ 7.79M$ -47.74M
Pretax Income
$ -71.81M$ -36.32M$ -57.56M$ -60.69M$ -33.28M$ -69.44M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -55.44M$ -36.32M$ -57.56M$ -60.69M$ -33.28M$ -69.44M
Basic EPS
$ -0.89$ -73.82$ -1.04$ -1.10$ -0.64$ -2.57
Diluted EPS
$ -0.89$ -7.80$ -1.04$ -1.10$ -0.64$ -2.57
Basic Average Shares
$ 5.95M-$ 55.22M$ 55.04M$ 51.83M$ 27.03M
Diluted Average Shares
$ 5.95M-$ 55.22M$ 55.04M$ 51.83M$ 27.03M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 77.22M$ 55.58M$ -59.10M$ 60.70M$ 41.55M$ 23.24M
Net Income From Continuing And Discontinued Operation
$ -55.44M$ -36.32M$ -57.56M$ -60.69M$ -33.28M$ -69.44M
Normalized Income
$ -63.70M$ -41.61M--$ -41.11M$ -21.71M
Interest Expense
-----$ 1.00K
EBIT
$ -67.78M$ -36.30M$ -57.56M$ -60.70M$ -41.55M$ -23.24M
EBITDA
$ -61.37M$ -33.01M$ -55.45M$ -58.43M$ -39.73M$ -22.71M
Currency in USD

Neurogene Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis